Skip to navigation Skip to main content

Elotuzumab (Empliciti)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews elotuzumab (Empliciti), indicated for the treatment of patients with multiple myeloma who have received 1 to 3 prior therapies, in combination with lenalidomide and dexamethasone.

Topics:

Drug Information Multiple Myeloma Slideshows Stat Consult
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides